Complete Filing Data
Cabaletta Bio, Inc. reported Stockholders Equity of $112.05 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cabaletta Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$167.9M | -$115.9M | -$67.7M | -$53.0M | -$46.3M | -$33.3M | -$16.9M | -$12.2M |
| Research And Development Expense | $142.7M | $97.2M | $55.4M | $39.3M | $32.5M | $21.4M | $11.7M | $4.5M |
| Operating Income Loss | -$172.2M | -$125.1M | -$74.7M | -$54.1M | -$46.3M | -$33.8M | -$18.7M | -$6.2M |
| Operating Expenses | $172.2M | $125.1M | $74.7M | $54.1M | $46.3M | $33.8M | $18.7M | $6.2M |
| General And Administrative Expense | $29.6M | $27.9M | $19.2M | $14.8M | $13.8M | $12.5M | $7.0M | $1.7M |
| Comprehensive Income Net Of Tax | -$167.8M | -$115.9M | -$67.6M | -$53.0M | -$46.3M | -$33.3M | -$22.3M | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $25.0K | -$39.0K | $86.0K | -$47.0K | $0.00 | $6.0K | ||
| Net Income Loss Available To Common Stockholders Basic | -$33.3M | -$22.3M | -$12.2M | |||||
| Interest Expense | $2.0M | $748.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$44.9M | -$45.1M | -$35.9M | -$30.6M | -$27.6M | -$25.0M | -$16.4M | -$14.5M | -$15.9M | -$11.4M | -$12.9M | -$12.9M | -$11.6M | -$11.1M | -$9.7M | -$8.4M | -$8.2M | -$7.5M | -$4.7M | -$3.4M | -$3.5M | -$9.3M |
| Research And Development Expense | $39.8M | $37.6M | $29.0M | $26.3M | $23.4M | $22.0M | $13.8M | $11.8M | $12.4M | $8.2M | $9.5M | $9.2M | $8.2M | $7.9M | $6.6M | $5.7M | $5.3M | $4.6M | $3.2M | $2.7M | $2.8M | $2.6M |
| Operating Income Loss | -$46.6M | -$45.9M | -$37.1M | -$33.0M | -$30.3M | -$28.0M | -$18.7M | -$15.9M | -$17.0M | -$11.8M | -$13.1M | -$13.0M | -$11.6M | -$11.1M | -$9.7M | -$8.4M | -$8.2M | -$7.9M | -$5.0M | -$3.8M | -$4.0M | -$3.1M |
| Operating Expenses | $46.6M | $45.9M | $37.1M | $33.0M | $30.3M | $28.0M | $18.7M | $15.9M | $17.0M | $11.8M | $13.1M | $13.0M | $11.6M | $11.1M | $9.7M | $8.4M | $8.2M | $7.9M | $5.0M | $3.8M | $4.0M | $3.1M |
| General And Administrative Expense | $6.8M | $8.3M | $8.1M | $6.8M | $6.9M | $6.1M | $4.9M | $4.1M | $4.5M | $3.6M | $3.5M | $3.8M | $3.4M | $3.3M | $3.2M | $2.8M | $2.9M | $3.3M | $1.8M | $1.1M | $1.2M | $491.0K |
| Comprehensive Income Net Of Tax | -$44.8M | -$45.1M | -$35.9M | -$30.6M | -$27.6M | -$25.1M | -$16.5M | -$14.5M | -$15.8M | -$11.4M | -$13.0M | -$13.1M | -$11.6M | -$11.1M | -$9.7M | -$8.4M | -$8.1M | -$7.5M | -$4.7M | -$3.4M | ||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $22.0K | $1.0K | $0.00 | $30.0K | $9.0K | -$77.0K | -$18.0K | -$3.0K | $47.0K | $40.0K | -$97.0K | -$152.0K | -$1.0K | $1.0K | -$3.0K | $1.0K | $11.0K | |||||
| Net Income Loss Available To Common Stockholders Basic | -$8.4M | -$8.2M | -$7.5M | -$4.7M | -$3.4M | -$8.9M | -$9.3M | |||||||||||||||
| Interest Expense | $584.0K | $571.0K | $294.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $112.1M | $152.3M | $236.2M | $104.5M | $118.0M | $109.5M | $138.3M | -$10.7M | -$249.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $83.0M | $164.0M | $193.2M | $81.6M | $122.2M | $101.4M | $136.2M | $33.0M | $1.0K |
| Debt Securities Available For Sale Unrealized Gain Loss | $25.0K | -$39.0K | $86.0K | -$47.0K | -$6.0K | $6.0K | |||
| Retained Earnings Accumulated Deficit | -$517.0M | -$349.1M | -$233.2M | -$165.6M | -$112.6M | -$66.3M | -$33.0M | -$12.5M | |
| Prepaid Expense And Other Assets Current | $5.3M | $2.7M | $3.2M | $2.3M | $2.3M | $4.9M | $4.3M | $977.0K | |
| Liabilities Current | $50.2M | $27.1M | $16.0M | $9.5M | $8.4M | $5.2M | $3.1M | $943.0K | |
| Liabilities And Stockholders Equity | $165.1M | $185.0M | $253.7M | $117.0M | $126.3M | $114.7M | $141.5M | $34.2M | |
| Common Stock Value | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $83.0M | $164.0M | $193.2M | $81.6M | $122.2M | $101.4M | $136.2M | $33.0M | |
| Assets Current | $138.9M | $166.7M | $244.5M | $108.8M | $124.5M | $113.5M | $140.6M | $34.0M | |
| Assets | $165.1M | $185.0M | $253.7M | $117.0M | $126.3M | $114.7M | $141.5M | $34.2M | |
| Additional Paid In Capital Common Stock | $629.0M | $501.4M | $469.4M | $270.1M | $230.5M | $175.8M | $171.3M | $1.8M | |
| Accrued Liabilities And Other Liabilities Current | $19.3M | $12.2M | $7.9M | $4.8M | $6.0M | $3.9M | $2.2M | $340.0K | |
| Accounts Payable Current | $6.6M | $4.9M | $4.5M | $2.5M | $2.3M | $1.2M | $920.0K | $603.0K | |
| Property Plant And Equipment Net | $1.9M | $2.7M | $2.5M | $2.6M | $1.4M | $890.0K | $815.0K | ||
| Other Assets Noncurrent | $5.2M | $2.3M | $1.7M | $565.0K | $357.0K | $299.0K | $101.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $111.6M | -$40.6M | $20.8M | -$34.8M | $103.2M | $33.0M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $1.6M | $1.5M | $1.2M | $223.0K | -$62.0K | -$119.0K | |||
| Short Term Investments | $50.6M | $0.00 | $48.0M | $24.9M | $0.00 | $7.2M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $25.0K | $0.00 | $39.0K | -$47.0K | $0.00 | $6.0K | |||
| Operating Lease Right Of Use Asset | $3.4M | $6.3M | $4.9M | $5.0M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Operating Lease Liability Noncurrent | $0.00 | $2.4M | $1.5M | $3.0M | $0.00 | ||||
| Operating Lease Liability Current | $3.5M | $4.0M | $3.6M | $2.2M | $0.00 | ||||
| Non Cash Lease Expense | $3.7M | $2.8M | $2.1M | $2.5M | $0.00 | ||||
| Liabilities | $53.0M | $32.7M | $17.5M | $12.4M | $8.4M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $21.1M | $11.0M | $2.0M | $13.7M | $0.00 | ||||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $787.0K | $4.2M | $0.00 | ||||||
| Finance Lease Right Of Use Asset | $15.7M | $7.0M | $0.00 | ||||||
| Finance Lease Principal Payments | $6.3M | $897.0K | $0.00 | ||||||
| Finance Lease Liability Noncurrent | $2.9M | $3.2M | $0.00 | ||||||
| Finance Lease Liability Current | $20.8M | $6.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $139.5M | $178.5M | $121.6M | $174.2M | $199.5M | $221.7M | $160.9M | $174.1M | $91.7M | $85.9M | $95.5M | $106.7M | $116.6M | $101.3M | $103.3M | $117.5M | $124.6M | $131.7M | -$26.1M | -$22.0M | -$19.1M | -$10.2M | -$1.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $60.2M | $145.6M | $131.8M | $170.6M | $178.6M | $175.3M | $115.5M | $128.1M | $93.8M | $61.2M | $47.2M | $59.6M | $118.3M | $99.5M | $97.3M | $108.7M | $112.1M | $131.0M | $71.0M | $75.3M | $80.2M | $9.8M | ||
| Debt Securities Available For Sale Unrealized Gain Loss | $22.0K | $1.0K | $30.0K | $9.0K | -$77.0K | -$18.0K | -$3.0K | $47.0K | $40.0K | -$97.0K | -$152.0K | -$1.0K | -$2.0K | -$3.0K | $1.0K | $11.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$475.0M | -$430.2M | -$385.0M | -$316.5M | -$285.9M | -$258.3M | -$212.4M | -$195.9M | -$181.4M | -$149.9M | -$138.4M | -$125.5M | -$98.7M | -$87.1M | -$76.0M | -$57.0M | -$48.6M | -$40.4M | -$27.6M | |||||
| Prepaid Expense And Other Assets Current | $4.6M | $3.7M | $2.8M | $2.5M | $3.0M | $3.6M | $1.8M | $1.2M | $1.9M | $2.3M | $1.9M | $2.2M | $1.6M | $2.2M | $3.7M | $2.5M | $3.7M | $3.1M | $708.0K | |||||
| Liabilities Current | $45.7M | $41.5M | $34.0M | $22.9M | $17.9M | $18.0M | $10.6M | $8.5M | $9.3M | $5.8M | $6.5M | $6.9M | $6.0M | $5.6M | $4.0M | $4.3M | $3.3M | $3.3M | $3.1M | |||||
| Liabilities And Stockholders Equity | $189.8M | $224.5M | $165.1M | $204.4M | $217.4M | $240.5M | $173.3M | $184.6M | $103.4M | $91.7M | $102.0M | $113.7M | $122.6M | $106.9M | $107.3M | $121.8M | $127.9M | $135.0M | $74.9M | |||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Cash And Cash Equivalents At Carrying Value | $60.2M | $145.6M | $131.8M | $170.6M | $178.6M | $175.3M | $115.5M | $128.1M | $93.8M | $61.2M | $47.2M | $59.6M | $118.3M | $99.5M | $97.3M | $108.7M | $112.1M | $131.0M | $71.0M | |||||
| Assets Current | $164.6M | $198.4M | $134.6M | $185.5M | $206.3M | $227.5M | $166.2M | $177.6M | $95.7M | $88.2M | $98.7M | $111.4M | $120.9M | $105.0M | $105.8M | $119.2M | $123.5M | $134.1M | $71.7M | |||||
| Assets | $189.8M | $224.5M | $165.1M | $204.4M | $217.4M | $240.5M | $173.3M | $184.6M | $103.4M | $91.7M | $102.0M | $113.7M | $122.6M | $106.9M | $107.3M | $121.8M | $127.9M | $135.0M | $74.9M | |||||
| Additional Paid In Capital Common Stock | $614.5M | $608.7M | $506.6M | $490.8M | $485.4M | $480.0M | $373.3M | $370.0M | $273.1M | $236.0M | $234.2M | $232.4M | $215.3M | $188.5M | $179.3M | $174.5M | $173.2M | $172.2M | $1.5M | |||||
| Accrued Liabilities And Other Liabilities Current | $16.2M | $13.9M | $8.3M | $12.8M | $6.3M | $4.7M | $4.5M | $4.0M | $3.2M | $4.5M | $4.0M | $3.0M | $4.3M | $3.2M | $2.7M | $3.3M | $2.3M | $1.3M | $1.9M | |||||
| Accounts Payable Current | $8.3M | $7.2M | $6.5M | $2.2M | $4.2M | $5.8M | $3.6M | $2.3M | $4.0M | $1.3M | $2.5M | $3.9M | $1.7M | $2.4M | $1.3M | $953.0K | $991.0K | $2.0M | $1.2M | |||||
| Property Plant And Equipment Net | $2.1M | $2.4M | $2.6M | $2.8M | $3.0M | $2.9M | $2.0M | $2.3M | $2.6M | $2.8M | $2.3M | $1.2M | $1.5M | $1.6M | $1.2M | $980.0K | $806.0K | $739.0K | $540.0K | |||||
| Other Assets Noncurrent | $3.6M | $2.5M | $2.4M | $2.5M | $2.3M | $2.4M | $984.0K | $685.0K | $581.0K | $689.0K | $965.0K | $985.0K | $324.0K | $318.0K | $300.0K | $239.0K | $238.0K | $104.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$17.9M | $12.2M | -$62.7M | -$4.2M | -$5.2M | $47.2M | ||||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | $617.0K | $13.0K | $48.0K | -$29.0K | |||||||||||||||||||
| Short Term Investments | $99.7M | $49.1M | $12.4M | $24.6M | $48.6M | $48.9M | $48.3M | $0.00 | $24.7M | $49.6M | $49.7M | $1.0M | $3.3M | $4.8M | $8.1M | $7.7M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $23.0K | $1.0K | $1.0K | -$29.0K | -$38.0K | -$21.0K | -$3.0K | $0.00 | -$209.0K | -$249.0K | -$152.0K | $1.0K | $3.0K | $12.0K | $11.0K | |||||||||
| Operating Lease Right Of Use Asset | $3.6M | $4.5M | $5.4M | $13.6M | $5.9M | $7.7M | $4.1M | $4.5M | $7.6M | |||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $580.0K | $1.5M | $7.3M | $0.00 | $765.0K | $1.7M | $2.0M | $2.5M | |||||||||||||||
| Operating Lease Liability Current | $3.6M | $4.0M | $4.0M | $7.9M | $7.4M | $7.4M | $2.5M | $2.2M | $2.2M | |||||||||||||||
| Non Cash Lease Expense | $881.0K | $1.4M | $452.0K | $0.00 | ||||||||||||||||||||
| Liabilities | $50.3M | $46.0M | $43.6M | $30.2M | $17.9M | $18.7M | $12.4M | $10.5M | $11.8M | |||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $14.9M | $0.00 | $0.00 | |||||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | $0.00 | $4.2M | ||||||||||||||||||||||
| Finance Lease Right Of Use Asset | $15.9M | $16.7M | $20.1M | |||||||||||||||||||||
| Finance Lease Principal Payments | $552.0K | $0.00 | ||||||||||||||||||||||
| Finance Lease Liability Noncurrent | $4.6M | $3.9M | $8.1M | |||||||||||||||||||||
| Finance Lease Liability Current | $17.6M | $16.4M | $15.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $20.9M | $19.5M | $11.3M | $6.9M | $5.8M | $4.4M | $2.3M | $606.0K |
| Net Cash Provided By Used In Operating Activities | -$131.1M | -$88.2M | -$53.5M | -$46.4M | -$34.1M | -$26.8M | -$16.0M | -$4.7M |
| Net Cash Provided By Used In Financing Activities | $100.3M | $11.7M | $187.6M | $33.0M | $48.9M | -$24.0K | $119.9M | $37.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.6M | -$528.0K | $954.0K | -$32.0K | -$2.6M | $524.0K | $3.4M | $977.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $7.4M | $3.9M | $3.0M | -$1.2M | $2.1M | $1.9M | $1.7M | $279.0K |
| Increase Decrease In Accounts Payable | $1.6M | $1.0M | $1.7M | -$28.0K | $975.0K | $555.0K | $246.0K | $234.0K |
| Payments To Acquire Property Plant And Equipment | $1.2M | $2.2M | $687.0K | $2.5M | $1.2M | $635.0K | $693.0K | |
| Net Cash Provided By Used In Investing Activities | -$50.3M | $47.3M | -$22.5M | -$27.2M | $6.0M | -$8.0M | -$693.0K | |
| Increase Decrease In Other Operating Assets | $2.9M | $584.0K | $1.1M | $208.0K | $58.0K | $198.0K | $101.0K | |
| Proceeds From Issuance Of Common Stock | $93.6M | $0.00 | $185.2M | $32.9M | $48.3M | -$192.0K | $71.2M | |
| Proceeds From Stock Options Exercised | $14.0K | $1.4M | $2.3M | $51.0K | $579.0K | $139.0K | $6.0K | |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $50.0M | $49.5M | $62.5M | $25.0M | $7.2M | $3.8M | ||
| Payments To Acquire Available For Sale Securities Debt | $99.0M | $0.00 | $84.3M | $49.8M | $0.00 | $11.1M | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 291.0K | 269.0K | 108.0K | 76.0K | 71.0K | 29.0K | ||
| Increase Decrease In Operating Lease Liability | -$4.2M | -$3.3M | -$2.5M | -$2.9M | $0.00 | |||
| Payments Of Stock Issuance Costs | $252.0K | $8.6M | $2.4M | $1.3M | $169.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.2M | $3.8M | $2.5M | $1.8M | $1.3M | $873.0K | $496.0K | |
| Net Cash Provided By Used In Operating Activities | -$30.8M | -$24.0M | -$12.6M | -$12.8M | -$8.7M | -$4.9M | -$2.3M | |
| Net Cash Provided By Used In Financing Activities | -$552.0K | $6.9M | $226.0K | $51.0K | $2.2M | -$44.0K | $49.7M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $53.0K | $394.0K | -$398.0K | -$93.0K | -$1.1M | -$1.2M | -$749.0K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.5M | -$3.5M | -$1.7M | -$3.0M | -$1.2M | -$797.0K | $352.0K | |
| Increase Decrease In Accounts Payable | $1.6M | $1.7M | $1.7M | $1.7M | -$329.0K | $1.2M | -$302.0K | |
| Payments To Acquire Property Plant And Equipment | $785.0K | $812.0K | $380.0K | $147.0K | $97.0K | $226.0K | $180.0K | |
| Net Cash Provided By Used In Investing Activities | -$785.0K | -$812.0K | $24.6M | -$49.9M | $2.4M | -$226.0K | -$180.0K | |
| Increase Decrease In Other Operating Assets | $76.0K | $659.0K | $16.0K | $628.0K | $1.0K | $4.0K | $28.0K | |
| Proceeds From Issuance Of Common Stock | $0.00 | $5.7M | -$232.0K | $0.00 | $2.2M | -$44.0K | ||
| Proceeds From Stock Options Exercised | $0.00 | $1.1M | $458.0K | $51.0K | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $0.00 | $25.0M | $0.00 | $2.5M | ||||
| Payments To Acquire Available For Sale Securities Debt | $0.00 | $0.00 | $49.8M | |||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | ||||||||
| Increase Decrease In Operating Lease Liability | -$1.1M | -$1.3M | -$570.0K | $0.00 | ||||
| Payments Of Stock Issuance Costs | $147.0K | $6.3M | $216.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.10 | -$2.34 | -$1.65 | -$1.81 | -$1.80 | -$1.44 | -$4.07 | -$6.87 |
| Common Stock Shares Authorized | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 100.5M | 50.7M | 47.8M | 29.4M | 28.9M | 24.1M | 24.0M | 3.8M |
| Common Stock Shares Issued | 100.5M | 50.7M | 47.8M | 29.4M | 28.9M | 24.1M | 24.0M | 3.8M |
| Earnings Per Share Basic | $-2.10 | $-2.34 | $-1.65 | $-1.81 | $-1.80 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.44 | -$0.73 | -$0.71 | -$0.62 | -$0.56 | -$0.51 | -$0.37 | -$0.37 | -$0.45 | -$0.39 | -$0.45 | -$0.45 | -$0.45 | -$0.45 | -$0.41 | -$0.36 | -$0.35 | -$0.33 | -$2.17 | -$1.87 | -$6.05 | -$9.47 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 29.0M | 29.0M | 21.1M | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 96.3M | 91.5M | 48.9M | 48.3M | 48.2M | 41.7M | 39.8M | 31.3M | 29.0M | 29.0M | 29.0M | 27.7M | 25.0M | 24.3M | 24.1M | 24.0M | 24.0M | 3.8M | |||||
| Common Stock Shares Issued | 96.3M | 91.5M | 48.9M | 48.3M | 48.2M | 41.7M | 39.8M | 31.3M | 29.0M | 29.0M | 29.0M | 27.7M | 25.0M | 24.3M | 24.1M | 24.0M | 24.0M | 3.8M | |||||
| Earnings Per Share Basic | $-0.44 | $-0.73 | $-0.71 | $-0.62 | $-0.56 | $-0.51 | $-0.37 | $-0.37 | $-0.45 | $-0.39 | $-0.45 | $-0.45 | $-0.45 | $-0.45 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.9M | $19.5M | $11.3M | $6.9M | $5.8M | $4.4M | $2.3M | $606.0K |
| Investment Income Interest | $6.0M | $10.0M | $7.0M | $1.2M | $24.0K | $494.0K | $1.7M | $235.0K |
| Stock Issued During Period Value Stock Options Exercised | $14.0K | $1.4M | $2.3M | $51.0K | $579.0K | $139.0K | $6.0K | |
| Depreciation | $1.6M | $1.7M | $1.4M | $1.2M | $733.0K | $354.0K | $104.0K | $0.00 |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $404.0K | $702.0K | $0.00 | $135.0K | $20.0K | $226.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $291.0K | $269.0K | $108.0K | $76.0K | $71.0K | $29.0K | ||
| Stock Issued During Period Value New Issues | $10.9M | $185.5M | $48.3M | |||||
| Accretion Expense | $532.0K | $405.0K | $408.0K | $685.0K | $0.00 | |||
| Other Operating Income Expense Net | $358.0K | $0.00 | ||||||
| Noninterest Expense Offering Cost | $0.00 | $293.0K | $0.00 | |||||
| Interest Paid Net | $1.7M | $748.0K | $0.00 | |||||
| Foreign Currency Transaction Loss Before Tax | $225.0K | $38.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.8M | $5.7M | $5.2M | $5.3M | $5.0M | $3.8M | $3.0M | $2.8M | $2.5M | $1.7M | $1.8M | $1.8M | $1.5M | $1.4M | $1.3M | $1.1M | $1.1M | $873.0K | $569.0K | $416.0K | $496.0K | $195.0K |
| Investment Income Interest | $1.8M | $1.4M | $1.5M | $2.4M | $2.7M | $3.0M | $2.2M | $1.4M | $1.1M | $351.0K | $150.0K | $53.0K | $3.0K | $6.0K | $10.0K | $23.0K | $40.0K | $410.0K | $381.0K | $444.0K | $458.0K | $48.0K |
| Stock Issued During Period Value Stock Options Exercised | $14.0K | $71.0K | $250.0K | $1.1M | $239.0K | $390.0K | $458.0K | $51.0K | $459.0K | $60.0K | $135.0K | |||||||||||
| Depreciation | $485.0K | $393.0K | $365.0K | $219.0K | $116.0K | $76.0K | ||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $662.0K | $0.00 | $376.0K | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $197.0K | $129.0K | $32.0K | $40.0K | $459.0K | $46.0K | ||||||||||||||||
| Stock Issued During Period Value New Issues | $5.7M | $93.8M | $24.9M | $7.7M | $2.2M | |||||||||||||||||
| Accretion Expense | $167.0K | $194.0K | $104.0K | $0.00 | ||||||||||||||||||
| Other Operating Income Expense Net | $498.0K | -$61.0K | $0.00 | $0.00 | ||||||||||||||||||
| Noninterest Expense Offering Cost | $0.00 | $60.0K | $0.00 | |||||||||||||||||||
| Interest Paid Net | $208.0K | $0.00 | ||||||||||||||||||||
| Foreign Currency Transaction Loss Before Tax | $29.0K | $0.00 |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.